Assyro AI

FDA Orange Book · active-ingredient family

Sodium nitrite

Sodium nitrite is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:SODIUM NITRITE · NDA 203922

1

Brand (NDA)

0

Generics (ANDA)

2

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution

ProductApplicantApplicationTEApproved
SODIUM NITRITERLDHOPE PHARMSNDA 203922Feb 14, 2012

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9687506Feb 10, 2030in 3 yr 8 mo
ProductU-3394
8568793Dec 24, 2031in 5 yr 7 mo
SubstanceProduct

Sodium nitrite — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.